Sara Colombetti

Sara received her Ph.D. in Molecular and Cellular biology at the San Raffaele Scientific Institute in Milan (Italy). After a post-doc in cancer immunotherapy at the Ludwig Institute for Cancer Research (Lausanne branch) and later at Cytos Biotechnology (Zurich) she joined Roche in 2009 as team leader in thePharmacology Department. In 2018, she was appointed Global Head of Oncology Discovery Pharmacology, and more recently Head of Translational Pharmacology, part of the Oncology Discovery Unit within the Roche pharma Research and Development (pRED) division. The focus of the group is the development of cutting edge preclinical models for the evaluation of pRED Oncology portfolio assets.